Illumina (NASDAQ:ILMN) develops and sells DNA sequencing machines and associated consumables that researchers and clinicians use to gain insights into diseases and help make better-informed treatment decisions.First, Seattle neighbor Microsoft (NASDAQ:MSFT) teamed up with Adaptive, employing its machine learning and artificial intelligence tools to help the company create a T-cell receptor antigen map (basically, a guide to which immune-system T-cells respond to which toxic or foreign substances).